SEC Form 4 · accession 0001415889-15-000128
Vistagen Therapeutics, Inc. · VTGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shawn Singh
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Jan 11, 2015
Accepted (ET)
Jan 13, 2015 · 5:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411685
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant for Common StockF1 | $10.00 | Jan 11, 2015 | A | 150,000 | A | Jan 11, 2015 | Jan 11, 2020 | Common Stock | 150,000 | 150,000 | I |
Explanation of responses
- F1Held by The 1997 Singh Family Trust U/R/D 5/29/97.